Dr. Fred R. Hirsch on Unmet Needs in Lung Cancer

Fast track designation has been granted by the FDA to PT217 for extensive stage small cell lung cancer with disease progression.

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Oncology nurses play a vital role in informing patients about the importance of molecular testing and brain imaging in EGFR-mutated lung cancer.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Oncology nurses provide patients with lung cancer the education and empathy needed to navigate treatment options and adverse event management.

Compared with docetaxel, adagrasib improved progression-free survival and objective response rate in patients with pretreated KRAS G12C–mutant non–small cell lung cancer.